Entasis Therapeutics' Series B - II Round

Entasis Therapeutics raised a round of funding on September 05, 2017.

Entasis Therapeutics is developing a portfolio of cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. The Company's deep pipeline…

Articles about Entasis Therapeutics' Series B - II Round: